cbd for seizures

A prospective open‐label trial of a CBD/THC cannabis oil in dravet syndrome

PURPOSE The purpose of this study was to establish a dose guideline for pure CBD therapy for seizure reduction. The mean dose of CBD achieved was 13.3 mg/kg/day of CBD (range 7–16 mg/kg/day). Based on the dose measurements below, this would be approximately 1 full dropper of CBD oil from the 500mg bottle of CBD oil. Initial research in …

A prospective open‐label trial of a CBD/THC cannabis oil in dravet syndrome Read More »

Aug 24 2019

Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial

ABSTRACT By November 2016, a total of 278 patients had completed the original randomized trials, and 264 (95%) enrolled in this open-label extension. Median treatment duration was 274 days (range 1-512) with a mean modal dose of 21 mg/kg/d, and patients received a median of 3 concomitant antiepileptic medications. Adverse events (AEs) occurred in 93.2% …

Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial Read More »

Aug 24 2019

CBD oil cut seizures in half for kids with Dravet syndrome

ABSTRACT The study included 199 patients, average age 9, who were divided into three groups. One group received 20 milligrams per kilogram (mg/kg) dose per day of a liquid form of Epidiolex, while the second group received 10 mg/kg per day, and the third group received a placebo. CBD products are derived from marijuana, but …

CBD oil cut seizures in half for kids with Dravet syndrome Read More »

Aug 24 2019

Cannabidiol Oil Safely Lessens Seizures in Treatment-resistant Children, Early Trial Data Show

ABSTRACT A team led by researchers at University of Saskatchewan, Canada, are conducting an open-label Phase 1 clinical study (NCT03024827) called CARE-E. Scientists are exploring the safety and impact of increasing doses of CBD-enriched cannabis herbal extract (CHE) used as add-on therapy in up 28 children (ages 1 to 10) with epileptic encephalopathy resistant to …

Cannabidiol Oil Safely Lessens Seizures in Treatment-resistant Children, Early Trial Data Show Read More »

Aug 24 2019

A prospective open‐label trial of a CBD/THC cannabis oil in dravet syndrome

Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial

CBD oil cut seizures in half for kids with Dravet syndrome

Cannabidiol Oil Safely Lessens Seizures in Treatment-resistant Children, Early Trial Data Show

JOIN OUR NEWSLETTER

CONNECT WITH US

About

LEARN

Shop

These statements have not been evaluated by the FDA. This product is not intended diagnose, treat, cure or prevent disease.